Search Results for: ObsEva Begins Phase III Clinical
Articles
March 17, 2017
ObsEva Begins Phase III Clinical Program March 17, 2017
ObsEva SA, a Swiss biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise...
